Abiopharma

New Form 144 - Mineralys Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001964306-25-000294 Size: 10 KB

New Form 8-K - JOINT Corp Filed: 2025-07-30 AccNo: 0001612630-25-000015 Size: 205 KB Item 2.02: Results of Operations and Financial Condition Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Item 9.01: Financial Statements and Exhibits

New Form 3 - Lantern Pharma Inc. Filed: 2025-07-30 AccNo: 0001641172-25-021588 Size: 3 KB

New Form 10-Q - DEXCOM INC Filed: 2025-07-30 AccNo: 0001093557-25-000243 Size: 7 MB

New Form 424B3 - Cingulate Inc. Filed: 2025-07-30 AccNo: 0001641172-25-021582 Size: 347 KB

New Form SC TO-C - DURECT CORP Filed: 2025-07-30 AccNo: 0001193125-25-169369 Size: 25 KB

New Form 8-K - PROTHENA CORP PUBLIC LTD CO Filed: 2025-07-30 AccNo: 0001193125-25-169367 Size: 284 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

New Form 8-K - Syra Health Corp Filed: 2025-07-30 AccNo: 0001641172-25-021576 Size: 198 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 424B3 - Tivic Health Systems, Inc. Filed: 2025-07-30 AccNo: 0001683168-25-005528 Size: 191 KB

New Form 10-Q - Guardant Health, Inc. Filed: 2025-07-30 AccNo: 0001576280-25-000246 Size: 9 MB